Related Experiment Video
Updated: Jan 7, 2026

07:20
Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
37.1K
Biomarkers
YoungSoo Kim1,2, Illhwan Cho2, Sunhee Lee2
1Amyloid Solution Inc., Seongnam, Gyeonggi-do, Korea, Republic of (South).
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|December 26, 2025
Summary
A new fluorescent compound, AS-YFluor, can detect amyloid-β42 (Aβ42) oligomers in blood plasma. This Alzheimer's disease (AD) biomarker detection tool shows promise for early AD diagnosis and monitoring disease progression.
Area of Science:
- Neuroscience
- Biochemistry
- Medical Diagnostics
Background:
- Amyloid-β42 (Aβ42) oligomers are key neurotoxic biomarkers implicated in Alzheimer's disease (AD) pathogenesis and progression.
- Current diagnostic tools for early-stage AD and preclinical detection of Aβ42 oligomers are limited, hindering clinical trial efficacy.
- Novel imaging probes are crucial for elucidating the role of Aβ42 oligomers and supporting early AD diagnosis.
Purpose of the Study:
- To introduce AS-YFluor, a novel fluorescent compound designed for selective detection of Aβ42 oligomers.
- To evaluate the diagnostic potential of AS-YFluor in distinguishing Alzheimer's disease patients from controls using blood plasma.
- To assess the utility of AS-YFluor in monitoring AD progression and differentiating between various cognitive states.
Main Methods:
- In vitro assays were performed to confirm the selectivity of AS-YFluor for Aβ42 oligomers.
- Diagnostic potential was assessed using biological samples (brain lysate, CSF, blood) from 5XFAD transgenic mice and controls.
- AS-YFluor was applied to blood plasma samples from 165 human participants (NC, AD, MCI, non-AD dementia) to analyze fluorescence signals.
Main Results:
- AS-YFluor demonstrated high specificity for Aβ42 oligomers, showing no cross-reactivity with other protein species or abundant blood proteins.
- The compound effectively differentiated between samples from 5XFAD mice and controls, validating its use in biological matrices.
- In human studies, AS-YFluor distinguished AD patients from normal controls and non-AD dementia subjects with high accuracy (>93% sensitivity and specificity for MCI vs. AD/NC).
Conclusions:
- AS-YFluor is a novel fluorescent agent capable of selectively detecting Aβ42 oligomer levels in the blood of Alzheimer's disease patients.
- The compound shows significant promise as a blood-based diagnostic tool for early AD detection and monitoring disease progression.
- AS-YFluor's versatility extends to non-clinical research applications for studying oligomer behavior.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

